Beyond Antibiotics: Emerging Strategies for Combating Bacterial Infection
May 04–07, 2026 | Village at Breckenridge, Breckenridge, CO, United States
Scientific Organizers:
Joseph P. Zackular, Kimberly Kline, Daria Van Tyne, and Mariana X. Byndloss
×
-
May 04–07, 2026 | Village at Breckenridge, Breckenridge, CO, United States
Scientific Organizers: Joseph P. Zackular, Kimberly Kline, Daria Van Tyne, and Mariana X. Byndloss
Joseph P. Zackular, PhD
University of Pennsylvania
Kimberly Kline, PhD
University of Geneva
Daria Van Tyne, PhD
University of Pittsburgh
Mariana X. Byndloss, PhD
Vanderbilt University Medical Center
Available Formats:
Supported by:
Livestream
In Person
On Demand
***Meeting program subject to change.
Available Formats: = Livestream = In Person = On DemandMonday, May 4, 2026
Fundraising
Booking Function
Merchandise Options
Registration Options
Registration
4:00–8:00 PM
Welcome Mixer
6:00–8:00 PM
Tuesday, May 5, 2026
Breakfast
7:00–8:00 AM
Poster Setup
7:30–8:00 AM
Poster Viewing
7:45–5:00 PM
Welcome Remarks
8:00–8:10 AM
Keynote Address
8:10–9:00 AM
Dianne K. Newman, California Institute of Technology
Rethinking AMR: How Heterogeneity in Metabolism Shapes Drug Resistance
Rethinking AMR: How Heterogeneity in Metabolism Shapes Drug Resistance
Phage Biology and Therapy: Basic
9:00–11:15 AM
Andrew Camilli, Tufts University
Phage Cocktails for the Control of Cholera
Phage Cocktails for the Control of Cholera
Katrine L. Whiteson, University of California, Irvine
Experimental Evolution of Gram Positive-Targeting Phages
Experimental Evolution of Gram Positive-Targeting Phages
Martha Clokie, University of Leicester
Getting Bacteriophages Closer to Clinical Development
Getting Bacteriophages Closer to Clinical Development
Kendal R Tinney, University of Oregon
Short Talk: Impacts of Nasal Nutrients on Staphylococcus aureus Physiology and Adaptation to Bacteriophage
Short Talk: Impacts of Nasal Nutrients on Staphylococcus aureus Physiology and Adaptation to Bacteriophage
Coffee Break
9:30–9:50 AM
Lunch
11:15–12:15 PM
Poster Session 1
12:00–2:30 PM
Symposia Spotlight 1: From Bench to Bedside: An emerging Roadmap for New Therapies
2:30–4:30 PM
Michael S Gilmore †, Harvard Medical School/Mass General Brigham
Efagins Evolved Independently to Target the Enterococcal Cell Wall
Efagins Evolved Independently to Target the Enterococcal Cell Wall
Charlie Mo, University of Wisconsin-Madison
Using Bacteriophages to Combat Drug Resistance and Virulence in Methicillin-Resistant Staphylococcus Aureus
Using Bacteriophages to Combat Drug Resistance and Virulence in Methicillin-Resistant Staphylococcus Aureus
Adeline Supandy, University of Pittsburgh
Distinct Receptors Shape Phage Activity and Antimicrobial Resistance in Klebsiella spp.
Distinct Receptors Shape Phage Activity and Antimicrobial Resistance in Klebsiella spp.
Jee-Yon Lee, University of California at Davis
Restoring Epithelial PPARγ Signaling Limits High-Fat Diet–Induced Susceptibility to Clostridioides difficile Infection
Restoring Epithelial PPARγ Signaling Limits High-Fat Diet–Induced Susceptibility to Clostridioides difficile Infection
Drew Joel Schwartz, Washington University School of Medicine
Using the Infant Gut Microbiome to Predict Sepsis and Tailor Antibiotics
Using the Infant Gut Microbiome to Predict Sepsis and Tailor Antibiotics
Tahoura Samad, MIT
Microbially-inspired Antidotes to Repurpose Toxic Compounds as Antimicrobials
Microbially-inspired Antidotes to Repurpose Toxic Compounds as Antimicrobials
Yash Sanjay Acharya †, JNCASR
Breaching the Bacterial Cell Envelope: A Peptidomimetic Strategy to Overcome Metabolic Dormancy and Complicated Infections
Breaching the Bacterial Cell Envelope: A Peptidomimetic Strategy to Overcome Metabolic Dormancy and Complicated Infections
Joshua Price, Harvard University
(S)-crizotinib Drives Host-mediated Clearance of Intracellular Pathogens by Targeting Cholesterol Trafficking
(S)-crizotinib Drives Host-mediated Clearance of Intracellular Pathogens by Targeting Cholesterol Trafficking
Coffee Available
4:30–5:00 PM
Phage Biology and Therapy: Applied
5:00–7:00 PM
Daria Van Tyne, University of Pittsburgh
Functional Genomics and Phage Therapy for Antibiotic-Resistant Bacterial Infections
Functional Genomics and Phage Therapy for Antibiotic-Resistant Bacterial Infections
Paul E. Turner, Yale University
Leveraging Evolution to Fight Antibiotic Resistance with Phage Therapy
Leveraging Evolution to Fight Antibiotic Resistance with Phage Therapy
Susan M. Lehman, U.S. Food and Drug Administration
An in vitro Preclinical Model of Phage Dosing for Localized Infections
An in vitro Preclinical Model of Phage Dosing for Localized Infections
Jennifer A. Schwartz, INTRALYTIX, INC.
Phage Control of Pathogens in Food Processing, Medicine, and Environmental Settings
Phage Control of Pathogens in Food Processing, Medicine, and Environmental Settings
On Own for Dinner
7:00–8:00 PM
Wednesday, May 6, 2026
Breakfast
7:00–8:00 AM
Harnessing the Microbiome for Infection: Basic
8:00–11:00 AM
Mariana X. Byndloss, Vanderbilt University Medical Center
Host-Microbiota Metabolic Interactions during Infectious Gastroenteritis
Host-Microbiota Metabolic Interactions during Infectious Gastroenteritis
Vanessa Sperandio, University of Wisconsin
Microbiota Control of EHEC Pathogenesis
Microbiota Control of EHEC Pathogenesis
Bärbel Stecher, TUM School of Life Sciences
Using Defined Microbiota Communities to Reveal Novel Insights into Colonization Resistance Against Salmonella
Using Defined Microbiota Communities to Reveal Novel Insights into Colonization Resistance Against Salmonella
Katy Patras, Baylor College of Medicine
Short Talk: Microbe-Based Strategies to Eradicate AMR Pathogens from the Vaginal Mucosa
Short Talk: Microbe-Based Strategies to Eradicate AMR Pathogens from the Vaginal Mucosa
Hallie Avalos, Vanderbilt
Short Talk: Salmonella Typhimurium Relies on Vitamin C Utilization for Expansion During Intestinal Inflammation
Short Talk: Salmonella Typhimurium Relies on Vitamin C Utilization for Expansion During Intestinal Inflammation
Noah Lyons, NC State University
Short Talk: Lachnospiraceae Bile Salt Hydrolases as Regulators of C. difficile Colonization Resistance and Pathogenesis
Short Talk: Lachnospiraceae Bile Salt Hydrolases as Regulators of C. difficile Colonization Resistance and Pathogenesis
Apollo Stacy, Cleveland Clinic
Short Talk: Dietary Nitrate Enhances Commensal-Mediated Antagonism of Oral Pathogens
Short Talk: Dietary Nitrate Enhances Commensal-Mediated Antagonism of Oral Pathogens
Coffee Break
9:00–9:20 AM
Poster Setup
11:00–1:00 PM
On Own for Lunch
11:00–5:00 PM
Poster Viewing
1:00–10:00 PM
Career Roundtable
3:00–4:30 PM
Coffee Available
4:30–5:00 PM
Harnessing the Microbiome for Infection: Applied
5:00–7:00 PM
Joseph P. Zackular, University of Pennsylvania
Leveraging Ecology to Design New Therapeutic Strategies Against Clostridioides Difficile
Leveraging Ecology to Design New Therapeutic Strategies Against Clostridioides Difficile
Julie Segre, NIH/NHGRI
Human Skin Microbiome: From Friends to Foes
Human Skin Microbiome: From Friends to Foes
Greg Medlock, Vedanta Biosciences
Microbiome Therapeutics in the Age of Multi-Drug Resistant Pathogens
Microbiome Therapeutics in the Age of Multi-Drug Resistant Pathogens
Amber Nguyen, University of Colorado Anschutz Medical Campus
Short Talk: Bacteriocins from Staphylococcus hominis Protect Against Skin Pathogens
Short Talk: Bacteriocins from Staphylococcus hominis Protect Against Skin Pathogens
Jason Pizzini †, Baylor College of Medicine
Short Talk: Engineering the Gut Microbiome to Resist Multidrug-Resistant Pathogens
Short Talk: Engineering the Gut Microbiome to Resist Multidrug-Resistant Pathogens
Social Hour with Dinner
7:00–8:00 PM
Poster Session 2
7:30–10:00 PM
Thursday, May 7, 2026
Breakfast
7:00–8:00 AM
Leveraging Immunity to Combat Bacterial Infection: Basic
8:00–11:00 AM
Kimberly Kline, University of Geneva
Host-Pathogen Interactions in Mixed-Species Infections
Host-Pathogen Interactions in Mixed-Species Infections
Victor Torres, St. Jude Children's Research Hospital
Impact of Nutrition on Host-Pathogen Interactions during ESKAPE Pathogen Infection
Impact of Nutrition on Host-Pathogen Interactions during ESKAPE Pathogen Infection
Raphael Valdivia, Duke University
Akkermansia Mediated Control of Mucosal Immunity
Akkermansia Mediated Control of Mucosal Immunity
Victor Choi, University of Oxford
Short Talk: Antimicrobial-Loaded Ultrasound-Responsive Agents (AURAs) for Treatment of Wound Infections
Short Talk: Antimicrobial-Loaded Ultrasound-Responsive Agents (AURAs) for Treatment of Wound Infections
Kai Yi E Lim, A*STAR Infectious Diseases Labs
Short Talk: Siglec F- expressing Nasal Resident Myeloid Cells Protect Against Airway Infection by Hypervirulent Klebsiella pneumoniae
Short Talk: Siglec F- expressing Nasal Resident Myeloid Cells Protect Against Airway Infection by Hypervirulent Klebsiella pneumoniae
Rochelle Glover, Children's Hospital of Philadelphia
Short Talk: mRNA-LNP Therapeutics for Clostridioides difficile Infection
Short Talk: mRNA-LNP Therapeutics for Clostridioides difficile Infection
Grant Norton, University of California San Diego
Short Talk: Enterobactin Immunization Enables Precision Targeting of Adherent-Invasive Escherichia coli in a Murine Model of Colitis
Short Talk: Enterobactin Immunization Enables Precision Targeting of Adherent-Invasive Escherichia coli in a Murine Model of Colitis
Coffee Break
9:00–9:20 AM
On Own for Lunch
11:00–5:00 PM
Symposia Spotlight 2: Pulling the Right Lever - Target Discovery for Future Therapies and Prevention
2:30–4:30 PM
Luke Joyce, University of Colorado Anschutz Medical Campus
Group B Streptococcus Glycolipids Protect Against Immune Cell Clearance During Host-Pathogen Interactions
Group B Streptococcus Glycolipids Protect Against Immune Cell Clearance During Host-Pathogen Interactions
Lindsey R Burcham, University of Tennessee, Knoxville
Iron Metabolism as a Key Regulator of Group B Streptococcus-Host Interactions
Iron Metabolism as a Key Regulator of Group B Streptococcus-Host Interactions
Kia Holt †, University of Illinois College of Medicine
The Acinetobacter baumannii Cyanide-Insensitive Oxidase is Required During Bloodstream Infection
The Acinetobacter baumannii Cyanide-Insensitive Oxidase is Required During Bloodstream Infection
Wendy Mok, UConn Health
Nutrient Availability Modulates Staphylococcus aureus Repair and Resuscitation Following Antibiotic Treatment
Nutrient Availability Modulates Staphylococcus aureus Repair and Resuscitation Following Antibiotic Treatment
Aanuoluwa Adekoya, University of Tennessee Knoxville
Quantitative Analysis of Microbial Physiology within Human Chronic Wound Infection Models
Quantitative Analysis of Microbial Physiology within Human Chronic Wound Infection Models
Ffion Hammond †, University of Oxford
Enrichment of Drug-Resistant Klebsiella Pneumoniae in the Gut Following Antibiotics Influences Subsequent Lung Challenge
Enrichment of Drug-Resistant Klebsiella Pneumoniae in the Gut Following Antibiotics Influences Subsequent Lung Challenge
Matt Barber, University of Oregon
Adaptation of Staphylococcus Aureus to Host and Microbial Defenses
Adaptation of Staphylococcus Aureus to Host and Microbial Defenses
Ahmed M. M Moustafa, Children's Hospital of Philadelphia
Enabling Precision Surveillance: A Genomics-Guided Approach to Rapidly Detect Circulating Pathogenic Lineages
Enabling Precision Surveillance: A Genomics-Guided Approach to Rapidly Detect Circulating Pathogenic Lineages
Coffee Available
4:30–5:00 PM
Leveraging Immunity to Combat Bacterial Infection: Applied
5:00–7:00 PM
Molly A Ingersoll, Institut Cochin & Institut Pasteur
Leveraging Mucosal Immunity in the Fight Against Recurrent Urinary Tract Infection
Leveraging Mucosal Immunity in the Fight Against Recurrent Urinary Tract Infection
Victor Nizet, University of California, San Diego School of Medicine
Novel Biomimetic Nanotherapies and Nanovaccines for AMR Pathogens
Novel Biomimetic Nanotherapies and Nanovaccines for AMR Pathogens
Andreas Peschel, Interfaculty Institute of Microbiology and Infection Medicine
Teichoic Acids at the Staphylococcus-Host Interface
Teichoic Acids at the Staphylococcus-Host Interface
Ann Marie Stanley, AstraZeneca
Monoclonal Antibodies to Prevent and Treat Bacterial Infections
Monoclonal Antibodies to Prevent and Treat Bacterial Infections
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
7:00–7:15 PM
Social Hour with Dinner
7:15–8:15 PM
Cash Bar
8:00–11:00 PM
Entertainment
8:00–11:00 PM
Friday, May 8, 2026
Departure
12:00–11:59 PM
Subscribe for Updates